| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Vp-administration | Interim CEO And Interim CFO
7 companies
Rubin Steven D is an Executive Vp-administration at OPKO HEALTH, INC. with holdings across 7 companies. Recent SEC Form 4 filings include 14 buys and 1 sell.
Estimated insider holdings value: $18.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | ENTX Entera Bio Ltd. | Director | Buy | 5,000 | $1.49 | $7,450.00 | +50.0% | - | - | |
| Feb 9, 2026 | ENTX Entera Bio Ltd. | Director | Buy | 10,000 | $1.20 | $12,000.00 | New | - | - | |
| Mar 19, 2025 | RDVT Red Violet, Inc. | Director | Sell | 10,000 | $38.93 | $389,300.00 | -6.6% | +23.8% | +0.1% | |
| Jan 5, 2024 | OPK Opko Health, Inc. | Executive Vp-administration | Buy | 10,000 | $0.87 | $8,669.00 | +0.2% | +53.0% | +66.6% | |
| Nov 10, 2023 | OPK Opko Health, Inc. | Executive Vp-administration | Buy | 10,000 | $1.30 | $13,000.00 | +0.2% | -19.0% | +20.6% | |
| May 25, 2023 | NAGE Niagen Bioscience, Inc. | Director | Buy | 7,000 | $1.46 | $10,220.00 | New | +2.1% | +118.2% | |
| Aug 26, 2020 | OPK Opko Health, Inc. | Executive Vp-administration | Buy | 10,000 | $3.99 | $39,943.00 | - | - | - | |
| Oct 25, 2019 | OPK Opko Health, Inc. | Executive Vp-administration | Buy | 15,000 | $1.50 | $22,500.00 | +0.3% | - | - | |
| May 9, 2019 | OPK Opko Health, Inc. | Executive Vp-administration | Buy | 10,000 | $2.14 | $21,442.00 | - | - | - | |
| Mar 6, 2019 | OPK Opko Health, Inc. | Executive Vp-administration | Buy | 8,000 | $2.56 | $20,452.18 | - | - | - |